Ads
related to: t-cell therapy- Resources & Support
Find Helpful Resources & Support
For An RR Multiple Myeloma Option.
- BCMA Targeting Option
Learn More About A Treatment Option
That Targets BCMA In RRMM Therapy.
- Resources & Support
Search results
Pulling out the stops: Deletion of regnase-1 promotes anti-tumor activity in NK cells
Medical Xpress· 13 hours agoNatural killer (NK) cells play a crucial role in the first line of host defense by eliminating...
Preventative drug providing hope for potential Type 1 diabetes patients in Colorado
CBS News· 5 hours agoDoctors at the Barbara Davis Center for Diabetes are encouraged by a relatively new treatment that...
Researchers discover vaccine originally created for HIV may also combat cancer
Medical Xpress· 2 days agoCytomegalovirus, or CMV, is a common virus that infects most people in their lifetimes and typically...
Cancer treatment may work best at the right time of day
Futurity· 1 day agoThe circadian clock can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy,...
St. Louis firm, backed by $200M in funding, gets regulatory nods to ‘expedite’ review of cancer drug...
The Business Journals· 3 days agoFood and Drug Administration’s Regenerative Medicine Advanced Therapy (RMAT) and European Medicines...
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology...
Benzinga· 3 days agoPlanegg/Martinsried, May 28, 2024 – Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of
Q&A: Quadruple therapies and the future of multiple myeloma treatment
Medical Xpress· 7 days agoOver the last decade, options have evolved from double, to triple to quadruple combination...
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
Morningstar· 3 days agoData From Newly FDA-Approved IMDELLTRA™ (tarlatamab-dlle) Further Reinforce Leadership in Bispecific T-Cell Engagers Overall Survival Data from Phase 3 ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 4 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Innovations in Breast Cancer Diagnosis and Treatment
New Jersey Business Magazine· 1 day agoAlthough New Jersey is often ranked among the top 10 states in the nation for breast cancer incidence and mortality, the state’s healthcare institutions...
Ads
related to: t-cell therapy